Fluocinonide
Product Images NDC 45802-151

5 FDA label images from Padagis Israel Pharmaceuticals Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fluocinonide (NDC 45802-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

C26h32f2o7 (C26h32f2o7)

C26h32f2o7 (C26h32f2o7)
Chemical structure of the active ingredient Fluocinonide, showing its steroid backbone with fluorine substitutions and acetate ester functional groups.*
FDA Label Image

Fluopar Carton (Fluopar Carton)

Fluopar Carton (Fluopar Carton)
Packaging label for Fluocinonide Cream USP 0.1%, branded as Fluopar, presented in a 30 g tube. The label includes the product name Fluopar in large white text on a purple background with 'Rx Only' indicated. It includes mention of a Skin Repair Complex containing Dimethicone Cream 5%, 4 fl oz/118 mL. The label is marked with NDC 59088-754-00 and shows that the product is by Padagis Israel Pharmaceuticals Ltd.*
FDA Label Image

Table 1 (Table 1)

Table 1 (Table 1)
A table presenting adverse reaction incidence rates for Fluocinonide Cream used once daily and twice daily, compared with Vehicle Cream used once or twice daily. The table lists headache, application site burning, nasopharyngitis, and nasal congestion along with corresponding frequency and percentage data for each treatment group.*
FDA Label Image

Table 2 (Table 2)

Table 2 (Table 2)
A data table comparing treatment outcomes between Fluocinonide Cream and vehicle groups with different dosing frequencies, showing subject clearance and treatment success percentages for once daily and twice daily applications.*
FDA Label Image

Table 3 (Table 3)

Table 3 (Table 3)
A table presenting clinical outcomes comparing Fluocinonide Cream administered once daily or twice daily versus vehicle (placebo) once daily or twice daily. The table shows the number and percentage of subjects cleared and those achieving treatment success across different treatment groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.